FibroGen, Inc. (NASDAQ:FGEN) Receives Consensus Recommendation of “Reduce” from Brokerages
Shares of FibroGen, Inc. (NASDAQ:FGEN – Get Free Report) have been assigned a consensus recommendation of “Reduce” from the six ratings firms that are covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation and four have assigned a hold recommendation to the company. The average 12-month target […]
More Stories
Jowell Global (NASDAQ:JWEL) Stock Price Down 3.1% – Should You Sell?
Jowell Global Ltd. (NASDAQ:JWEL – Get Free Report) traded down 3.1% on Monday . The stock traded as low as...
UC Asset (OTCMKTS:UCASU) Shares Down 22.2% – Should You Sell?
UC Asset LP (OTCMKTS:UCASU – Get Free Report)’s stock price traded down 22.2% during trading on Monday . The stock...
Eramet (OTCMKTS:ERMAY) Trading 0.1% Higher – Here’s What Happened
Eramet S.A. (OTCMKTS:ERMAY – Get Free Report)’s stock price traded up 0.1% on Monday . The company traded as high...
Purple Biotech (NASDAQ:PPBT) Stock Price Up 0.9% – Here’s Why
Purple Biotech Ltd. Sponsored ADR (NASDAQ:PPBT – Get Free Report)’s share price traded up 0.9% during mid-day trading on Monday...
JMP Securities Issues Positive Forecast for Exelixis (NASDAQ:EXEL) Stock Price
Exelixis (NASDAQ:EXEL – Free Report) had its price objective raised by JMP Securities from $47.00 to $50.00 in a report...
Ramsay Health Care (OTCMKTS:RMYHY) Trading Up 1.4% – What’s Next?
Shares of Ramsay Health Care Ltd. Unsponsored ADR (OTCMKTS:RMYHY – Get Free Report) rose 1.4% during mid-day trading on Monday...